Episode 179 | Michelle Lott, Principal and Founder at LeanRAQA | FDA and MDR Updates - Project Medtech

In this episode, Michelle Lott at LeanRAQA and Duane Mancini discuss the QMSR, FDA e-start program, 513g vs. presubmission meeting, MDR update and so much more.

Episode 179 | Michelle Lott, Principal and Founder at LeanRAQA | FDA and MDR Updates

Om avsnittet

Fler avsnitt

Episode 279 | Melissa Muller, Founder & Principal Consultant at Muller Advisory Company | The First Five Things Medtech Founders Need to Know Before They Scale

Episode 278 | Staci Miller, Founder of Gen UX Consulting | The First Five Things You Need to Know About Human Factors Validation Testing

Episode 277 | Merom Klein, Principal at Courage Growth Partners | Building Courage in Medtech: Turning Fear Into Adoption, Investment & Innovation

Episode 276 | Ashkon Rasooli, Founder & CEO of EnGenius Solutions LLC | Beyond Compliance: Building Quality Systems That Give Medtech Companies an Edge

Episode 275 | Shannon Clark, Founder & President of HavenSafe | From Human Factors to Ending Homelessness

Episode 274 | Joe Tumolo, Founder & President at JTSC | Why Relationships Win in MedTech Commercialization

Episode 273 | Caron Trumbo, Vice President of Operations at VirginiaBio | Building a Biotech Ecosystem That Actually Works

Episode 272 | Mike Monovoukas, CEO & Co-founder at AcuityMD | The Future of Medtech Commercialization: AI, Data, and Smarter Growth

Episode 271 | Christopher Gates, Founder & CEO of arsMedSecurity | The First Five Things You Need to Know About Medical Device Cybersecurity

Episode 270 | Franco Kraiselburd, Founder & CEO, Asclepii | Reimagining Wound Care Through Accessible Innovation